197 related articles for article (PubMed ID: 20037158)
1. Smad3 protein levels are modulated by Ras activity and during the cell cycle to dictate transforming growth factor-beta responses.
Daly AC; Vizán P; Hill CS
J Biol Chem; 2010 Feb; 285(9):6489-97. PubMed ID: 20037158
[TBL] [Abstract][Full Text] [Related]
2. Epithelial to mesenchymal transition in Madin-Darby canine kidney cells is accompanied by down-regulation of Smad3 expression, leading to resistance to transforming growth factor-beta-induced growth arrest.
Nicolás FJ; Lehmann K; Warne PH; Hill CS; Downward J
J Biol Chem; 2003 Jan; 278(5):3251-6. PubMed ID: 12435725
[TBL] [Abstract][Full Text] [Related]
3. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
4. Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta.
Mori Y; Chen SJ; Varga J
Exp Cell Res; 2000 Aug; 258(2):374-83. PubMed ID: 10896788
[TBL] [Abstract][Full Text] [Related]
5. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
Levy L; Hill CS
Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
[TBL] [Abstract][Full Text] [Related]
6. TGF-β/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression: IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION.
Zhao J; Liu J; Lee JF; Zhang W; Kandouz M; VanHecke GC; Chen S; Ahn YH; Lonardo F; Lee MJ
J Biol Chem; 2016 Dec; 291(53):27343-27353. PubMed ID: 27856637
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
8. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
[TBL] [Abstract][Full Text] [Related]
9. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 interacts with Smad3 and regulates Smad3-mediated TGF-beta signaling during oxidative stress responses.
Li H; Sekine M; Seng S; Avraham S; Avraham HK
PLoS One; 2009 Sep; 4(9):e7091. PubMed ID: 19768112
[TBL] [Abstract][Full Text] [Related]
11. The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3.
Kim SG; Kim HA; Jong HS; Park JH; Kim NK; Hong SH; Kim TY; Bang YJ
Mol Biol Cell; 2005 Oct; 16(10):4672-83. PubMed ID: 16093355
[TBL] [Abstract][Full Text] [Related]
12. ATOH8 binds SMAD3 to induce cellular senescence and prevent Ras-driven malignant transformation.
Liu X; Li X; Wang S; Liu Q; Feng X; Wang W; Huang Z; Huang Y; Wu J; Cai M; Cai X; Xu X; Cai J; Li M
Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2208927120. PubMed ID: 36626550
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic ras represses transforming growth factor-beta /Smad signaling by degrading tumor suppressor Smad4.
Saha D; Datta PK; Beauchamp RD
J Biol Chem; 2001 Aug; 276(31):29531-7. PubMed ID: 11371552
[TBL] [Abstract][Full Text] [Related]
14. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition.
Do TV; Kubba LA; Du H; Sturgis CD; Woodruff TK
Mol Cancer Res; 2008 May; 6(5):695-705. PubMed ID: 18505915
[TBL] [Abstract][Full Text] [Related]
16. Ras inhibits TGF-β-induced KLF5 acetylation and transcriptional complex assembly via regulating SMAD2/3 phosphorylation in epithelial cells.
Guo P; Xing C; Fu X; He D; Dong JT
J Cell Biochem; 2020 Mar; 121(3):2197-2208. PubMed ID: 31724223
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta signaling in colon cancer cells.
Li F; Cao Y; Townsend CM; Ko TC
World J Surg; 2005 Mar; 29(3):306-11. PubMed ID: 15711891
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor β1 promotes invasion of human JEG-3 trophoblast cells via TGF-β/Smad3 signaling pathway.
Huang Z; Li S; Fan W; Ma Q
Oncotarget; 2017 May; 8(20):33560-33570. PubMed ID: 28432277
[TBL] [Abstract][Full Text] [Related]
19. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
[TBL] [Abstract][Full Text] [Related]
20. Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression.
Kohn EA; Yang YA; Du Z; Nagano Y; Van Schyndle CM; Herrmann MA; Heldman M; Chen JQ; Stuelten CH; Flanders KC; Wakefield LM
Mol Cancer Res; 2012 Oct; 10(10):1389-99. PubMed ID: 22878587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
